+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Clinical Investigator Career Development Award (2026-2029)

Lymphoma Research Foundation

KEY DATES

Application Release Date: June 2, 2025

Application Deadline: September 4, 2025 at 5:00 PM EST

Peer Review Process: September – November 2025

Applicant Notification Date: December 2025

Earliest Project Start Date: March 1, 2026

Latest Project Start Date: July 1, 2026

The Lymphoma Research Foundation maintains a strong commitment to supporting early career investigators and ensuring they can build a successful career in the field of lymphoma research. The Clinical Investigator Career Development Award (CDA) Program is designed to support physician investigators at the level of advanced fellow or junior faculty member who will contribute to the development of new lymphoma therapies and diagnostic tools. Eligible investigators must have no greater than six years of experience beyond completion of their fellowship or post-doctoral training (the six-year limit may be non-sequential in cases of pregnancy or illness).

The goal of the program is to prepare physician investigators to design and administer clinical research studies in lymphoma and assume primary responsibilities for clinical research, protocol writing, Institutional Review Board (IRB) submission and publication. As such, a Career Development Plan is required as part of the Grant Application. The proposed research plan should also develop the necessary knowledge and clinical research skills relevant to the investigator’s career goals. The Grant is designed to provide physician investigators with support to spend 35-50 percent of their time implementing clinical research studies in lymphoma.

The Foundation’s Clinical Investigator Career Development Award provides a total of $375,000 to grantees over three years. The Grant provides salary support in the amount of $120,000 per year. Incidental funds of $5,000 per year may be budgeted for research supplies or professional development expenses such as tuition, registration fees, and travel for courses and meetings that are integral to the Career Development Plan. This Grant does not provide institutional overhead.

AI Based Application Success Predictor

1. 🎓 Career-Stage Fit & Eligibility

LRF prioritizes early-career investigators through its core schemes:

Postdoctoral Fellowships: For PhD or MD holders within 2–5 years post-degree, dedicating ≥80% time to research

Clinical Investigator Career Development Awards (CDA): For clinically trained MDs within 5 years post-residency, committing ≥35–50% protected research time on clinical lymphoma research .

Lymphoma Scientific Research Mentoring Program (LSRMP): Includes a mentorship workshop and follow-up support, targeting lab and clinical juniors 

2. 🔬 Scientific Excellence & Clinical Relevance

Fundamental quality matters: Proposals must be hypothesis-driven, methodologically sound, and relevant to improving lymphoma diagnosis, treatment, or outcomes 

CDAs must involve human subjects and clinical translational elements, not purely lab-based work .

🤝 Mentorship & Institutional Backing

A primary mentor (senior faculty) from your home institution is mandatory—especially for CDA and fellowships. You may add associate mentors from other institutions if relevant.

Ensure your institution demonstrates formal support and confirms protected research time.

📈 Track Record & Promise

Successful candidates typically have strong publication records, prior abstracts/grants, and demonstrated potential in lymphoma research 

For CDAs and fellowships, confirm prior productivity and ability to carry out independent research.

🧭 Mentorship Program Participation

The LSRMP offers structured mentoring and networking. Accepted scholars participate in workshops and receive professional-development grants (~$10K).

This tracks into the broader aim of building future lymphoma research leaders.

🗓️ On-Time, Complete Application

Applications are annual (e.g., 2026 cycle LOI deadline: Sept 4, 2025). No LOI required unless specified 

Complete applications must include all required documents—project plan, biosketches, mentor letters, protected time statements—and be submitted via their portal.

💰 Appropriate Budgeting

Budgets should be realistic, covering salary support, research expenses, and development (e.g., CDAs offer 3-year salary + expenses; postdoc fellowships ~$195K total) .

Justify each cost clearly.

🧪 Peer Review by Expert SAB

All proposals are assessed by LRF’s Scientific Advisory Board, a panel of ~45 lymphoma experts.

Priority is given to innovative, collaborative, and high-impact proposals.

📝 Summary Table

Predictor	What to Demonstrate
Career-stage alignment	Within 5 years post-degree or residency; senior mentors in place
Scientific rigor	Hypothesis-driven, methodologically strong, and clinically relevant proposals
Research commitment	≥80% research time for fellowships; ≥35–50% for CDAs
Mentor & institutional support	Strong primary mentor; protected time and resource commitment
Track record	Publications, abstracts, previous awards
Participation in LSRMP	Engage in mentoring program; attend workshop
Budget justification	Realistic salary and research cost estimates
Complete on-time application	Use portal; include all documents by deadline
Innovation & impact	Focus on novel approaches, translational potential, and collaboration

🛠 Pro Tips to Strengthen Your Application

Choose the right grant: Postdoc Fellowship, CDA, or LSRMP.

Secure a strong mentor and confirm their time and support.

Design a clinically relevant project with clear endpoints and feasibility.

Highlight protected time and institutional commitment.

Use the mentoring program to build your network and capacity.

Budget accurately for salary, research, and training costs.

Polish all documents, especially mentor letters and biosketches.

Submit early, using deadlines as firm targets.

Specialties

Clinical Trials

Neurosciences

Eligibility Requirements

To account for training delays or furloughs that may have occurred as a result of the COVID-19 pandemic, the Foundation is temporarily extending the maximum eligibility for each track by one year, the new limits are noted in the section below.

1. Applicants must be licensed physicians at an academic or nonprofit clinical research institution in the United States or Canada for the duration of the Lymphoma Research Foundation Clinical Investigator Career Development Award, and intending to pursue a career in lymphoma clinical research. Applicants based at the NIH or another U.S. government entity are not eligible to apply for Lymphoma Research Foundation CDAs. Citizenship or permanent residency is not required for general CDA eligibility, but may affect eligibility for Health Equity Initiative funds.

2. Applicants for this award should be clinical physicians in one of the ACGME accredited specialties (e.g., hematology/oncology, pediatrics, pathology, dermatology, radiation oncology).

3. The applicant must be an advanced fellow or junior faculty member with at least 2 years (24 months) of fellowship or postdoctoral training and no greater than six years of experience beyond completion of his/her fellowship or postdoctoral training (the six year limit may be non-sequential) at the start of the award period (March 1, 2026).

4. Persons with non-traditional career tracks are encouraged to apply. They should have participated in developing new therapeutics and/or diagnostic tools for lymphoma.

5. Applicants must demonstrate that they already possess a broad knowledge of lymphoma biology and treatment and their desire to apply this knowledge to developing and evaluating new treatments.

6. The applicant must spend 35 to 50 percent of their time in research. This time should be free of major patient care, teaching or administrative responsibilities.

7. The applicant will have primary responsibility for the design, protocol writing, IRB submission, conduct, analysis and publication of one or more clinical trials during the award period.

8. Please note: The CDA recipient will not be permitted to hold any other career development award during the award period of the LRF grant. Examples of grants which fall in this category include NIH K-series awards, American Cancer Society Clinician Scientist Development Grant, ASH Scholar Awards, Leukemia and Lymphoma Society Career Development Program Grants (any level of Fellow or Scholar grants) and/or any grant termed a “career development award” or which supports primarily principal investigator (PI) salary. Lymphoma Research Foundation CDA Grantees may not simultaneously hold career development awards from other foundations even if there are no overlapping expenses with the Lymphoma Research Foundation grant. Supply and material costs for the clinical research project should be supported by institutional funds or another grant which is not a career development award; funds from an NIH Institutional Training grant (T32/K12 or equivalent) are considered part of the “institutional funds” category and are allowable. The percent of research time for the PI on all active grants should not add up to more than 100%. The Foundation must be informed as to the sources and the amounts of all extramural/noninstitutional funding received by the CDA recipient during the term of the Lymphoma Research Foundation Grant, and reserves the right to determine that the Grant may not be held concurrent with other funding.

9. All Lymphoma Research Foundation applications are self-initiated. The Foundation does not invite applications from selected individuals, institutions, or laboratories.

Eligible Countries:

Canada

United States

Sponsor Details

Sponsor Institute/Organizations: Lymphoma Research Foundation

Sponsor Type: Corporate/Non-Profit

Address: Wall Street Plaza, 88 Pine St Suite 2400, New York, NY 10005, United States

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity